92.60
前日終値:
$93.59
開ける:
$94.17
24時間の取引高:
254.88K
Relative Volume:
0.81
時価総額:
$1.55B
収益:
$5.82B
当期純損益:
$-373.54M
株価収益率:
-4.1072
EPS:
-22.546
ネットキャッシュフロー:
$-87.01M
1週間 パフォーマンス:
+7.08%
1か月 パフォーマンス:
-4.32%
6か月 パフォーマンス:
+536.97%
1年 パフォーマンス:
+227.79%
Agilon Health Inc Stock (AGL) Company Profile
Compare AGL vs HCA, THC, EHC, FMS, DVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
AGL
Agilon Health Inc
|
92.60 | 1.55B | 5.82B | -373.54M | -87.01M | -22.55 |
|
HCA
Hca Healthcare Inc
|
421.21 | 91.19B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
263.46 | 21.21B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
121.04 | 11.94B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.23 | 11.83B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
DVA
Davita Inc
|
181.33 | 11.57B | 13.84B | 1.10B | 1.49B | 10.42 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-20 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-25 | アップグレード | Citigroup | Neutral → Buy |
| 2025-04-08 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | アップグレード | Citigroup | Sell → Neutral |
| 2025-01-10 | 開始されました | Needham | Hold |
| 2024-12-16 | 開始されました | Macquarie | Neutral |
| 2024-12-11 | 開始されました | Bernstein | Mkt Perform |
| 2024-11-11 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | ダウングレード | Citigroup | Neutral → Sell |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-04-22 | 開始されました | Citigroup | Neutral |
| 2024-03-06 | 開始されました | Barclays | Underweight |
| 2024-02-26 | ダウングレード | Jefferies | Buy → Hold |
| 2024-02-26 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | ダウングレード | Stifel | Buy → Hold |
| 2024-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-01-05 | ダウングレード | Truist | Buy → Hold |
| 2023-12-11 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-11-21 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-10-20 | 開始されました | The Benchmark Company | Buy |
| 2023-06-13 | 開始されました | Evercore ISI | In-line |
| 2022-12-09 | 開始されました | Stifel | Buy |
| 2022-09-14 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-09-12 | 開始されました | Goldman | Buy |
| 2022-09-07 | 再開されました | Truist | Buy |
| 2022-06-24 | 開始されました | BTIG Research | Neutral |
| 2022-03-30 | 開始されました | Guggenheim | Buy |
| 2021-10-20 | 開始されました | Jefferies | Buy |
| 2021-09-27 | 開始されました | SVB Leerink | Outperform |
| 2021-09-10 | 開始されました | Cowen | Outperform |
| 2021-05-11 | 開始されました | William Blair | Outperform |
| 2021-05-10 | 開始されました | BofA Securities | Buy |
| 2021-05-10 | 開始されました | Deutsche Bank | Buy |
| 2021-05-10 | 開始されました | Goldman | Buy |
| 2021-05-10 | 開始されました | JP Morgan | Overweight |
| 2021-05-10 | 開始されました | Truist | Buy |
| 2021-05-10 | 開始されました | Wells Fargo | Overweight |
| 2021-05-10 | 開始されました | Wolfe Research | Outperform |
すべてを表示
Agilon Health Inc (AGL) 最新ニュース
A Pennsylvania doctor group serving more than 200,000 patients will join agilon’s Medicare care program. - Stock Titan
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO - Business Wire
Why Is AGL Stock Rising Today? - Stocktwits
agilon health Inc (AGL) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Most Volatile Stocks in the US (September 2026) - Investing.com
A Look at Agilon Health Inc (AGL) After 5.0% Decline -- GF Value $91.63 vs Price $87.89 - GuruFocus
agilon health Inc (AGL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - Yahoo Finance
agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference - Business Wire
Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL) - The Globe and Mail
J.P. Morgan Maintains Agilon Health(AGL.US) With Sell Rating, Raises Target Price to $85 - Moomoo
Truist reiterates Hold on agilon health stock, $112 target By Investing.com - Investing.com Nigeria
Why Fast-paced Mover Agilon (AGL) Is a Great Choice for Value Investors - Eastern Progress
Is Agilon Health Inc (AGL) Overvalued After 4.2% Rally? GF Value - GuruFocus
agilon health to Participate in Upcoming Conferences - Yahoo Finance
Agilon Health (NYSE:AGL) Trading Up 5.4%Here's Why - MarketBeat
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
AQR Capital Management Trims Agilon Health (AGL) Stake Amid Stoc - GuruFocus
agilon health (AGL) insider’s 17-share move is just tax withholding - Stock Titan
Agilon Health (AGL) Q2 2026 Earnings Call Transcript - AOL.com
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
Agilon Health (NYSE:AGL) Trading 8.5% HigherHere's What Happened - MarketBeat
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
AGL|agilon health inc|Price:92.730|Chg%:-0.910 - TradingKey
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call - Yahoo Finance
Agilon Health (NYSE:AGL) Valuation Debate Grows After Guidance - Kalkine Media
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A - Stock Titan
Is Agilon Health Inc (AGL) a Bargain After 10.7% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Group (AGL) discloses 3.9% beneficial stake in agilon health - Stock Titan
Citigroup Upgrades Agilon Health to Neutral From Sell, Adjusts Price Target to $115 From $105 - marketscreener.com
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $115 - Moomoo
AGILON HEALTH, INC. : CITIGROUP RAISES TO NEUTRAL FROM SELL; RAISES TARGET PRICE TO $115 FROM $105 - Bitget
agilon health, inc. (AGL) Stock Analysis: Navigating the Healthcare Sector with a 13.42% Potential Upside - DirectorsTalk Interviews
Citi Upgrades Agilon Health(AGL.US) to Hold Rating, Raises Target Price to $115 - Moomoo
Weekly Recap: Cash, debt & guidance and CHF rollout, clinical expansion - TradingView
Agilon Health Earnings Call Signals Profitable Turnaround - The Globe and Mail
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $95 - Moomoo
Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable? - Yahoo Finance
agilon health: The Q2 Inflection Is Real (NYSE:AGL) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), Qiagen (QGEN) and Coherus Biosciences (CHRS) - The Globe and Mail
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $140 - Moomoo
Baird Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $116 - Moomoo
Evercore Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $125 - Moomoo
agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside - TradingView
Agilon Health (NYSE:AGL) Trading Down 9.9%What's Next? - MarketBeat
agilon health (AGL) Is Up 16.4% After Q2 Return To Profitability And Raised 2026 Outlook - simplywall.st
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $125 - Moomoo
Agilon Health Q2 Earnings Call Highlights - TradingView
Agilon Health Inc (AGL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):